Case studies

The 2018 AMR Benchmark has examined what pharmaceutical companies are doing to help bring antimicrobial resistance under control. Here it presents three case studies of how companies ensuring antimicrobials are used conservatively while also improving appropriate access to these essential medicines.

Learn more

View our detailed overview of each company’s performance